DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award
This grant funds research focused on clinical outcomes and biomarkers related to Amyotrophic Lateral Sclerosis (ALS).
About this program
The DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award aims to support innovative research that advances the understanding of clinical outcomes and biomarkers in ALS. This program is designed for researchers and institutions dedicated to improving the lives of individuals affected by ALS through scientific discovery and innovation. By funding projects that explore new methodologies and technologies, the program seeks to foster advancements that can lead to better diagnosis, treatment, and management of ALS.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and research entities with a focus on ALS research.